Search
Search Constraints
You searched for: Author/Creator Rudwaleit, MLimit your search
- Rudwaleit, M [remove] 51
- 616.723005 51
- Rheumatism -- Periodicals 51
- AA, amino acid -- AS, ankylosing spondylitis -- IFNγ, interferon γ -- IL, interleukin -- MACS, magnetic activated cell sorting -- PB, peripheral blood -- PBMCs, peripheral blood mononuclear cells -- RA, rheumatoid arthritis -- SEB, Staphylococcus enterotoxin B -- TNFα, tumour necrosis factor α 1
- ACR, American College of Rheumatology -- AS, ankylosing spondylitis -- ASAS, Assessments in Ankylosing Spondylitis working group -- BASDAI, Bath ankylosing spondylitis disease activity index -- BASFI, Bath ankylosing spondylitis functional index -- BASMI, Bath ankylosing spondylitis metrology index -- DCART, disease controlling anti-rheumatic therapy -- DMARD, disease modifying antirheumatic drug -- NSAID, non-steroidal anti-inflammatory drug -- RCT, randomised controlled trial -- SMARD, symptom modifying anti-rheumatic drug -- SRM, standardised response mean -- TNFα, tumour necrosis factor α -- VAS, visual analogue scale 1
- AS, ankylosing spondylitis -- ASAS, Ankylosing Spondylitis Assessment Group -- BASDAI, Bath Ankylosing Spondylitis Disease Activity Index -- BASFI, Bath Ankylosing Spondylitis Functional Index -- BASMI, Bath Ankylosing Spondylitis Metrology Index -- BASRI, Bath Ankylosing Spondylitis Radiology Index -- CRP, C reactive protein -- DMARD, disease modifying antirheumatic drug -- ESR, erythrocyte sedimentation rate -- LRT, likelihood ratio test -- MRI, magnetic resonance imaging -- NSAID, non-steroidal anti-inflammatory drug -- TNFα, tumour necrosis factor α 1
- AS, ankylosing spondylitis -- BASDAI, Bath AS Disease Activity Index -- RCT, randomised controlled trial -- TNFα, tumour necrosis factor α 1
- AS, ankylosing spondylitis -- BASDAI, Bath AS Disease Activity Score -- BASMI, Bath AS Metrology Index -- CS, cervical spine -- LS, lumbar spine -- MRI, magnetic resonance imaging -- mSASSS, modified Stokes AS Spinal Score -- RCT, randomised controlled trial -- TNF, tumour necrosis factor -- TS, thoracic spine 1
- AS, ankylosing spondylitis -- BASDAI, Bath Ankylosing Spondylitis Disease Activity Index -- BASFI, Bath Ankylosing Spondylitis Functional Index -- BASMI, Bath Ankylosing Spondylitis Metrology Index -- CRP, C reactive protein -- DMARD, disease modifying antirheumatic drug -- NSAID, non-steroidal anti-inflammatory drug -- RA, rheumatoid arthritis -- SF-36, Short Form-36 -- SSZ, sulfasalazine 1
- AS, ankylosing spondylitis -- BASFI, Bath Ankylosing Spondylitis Functional Index -- BASMI, Bath Ankylosing Spondylitis Metronomy Index -- BASRI, Bath Ankylosing Spondylitis Radiological Index -- CS, cervical spine -- LS, lumbar spine -- MRI, magnetic resonance imaging -- SASSS, Stokes AS spinal score -- SDD, smallest detectable distance -- TNF, tumour necrosis factor -- TS, thoracic spine -- VU, vertical unit 1
- AS, ankylosing spondylitis -- CRP, C reactive protein -- CT, computed tomography -- DMARD, disease modifying antirheumatic drug -- ESR, erythrocyte sedimentation rate -- ESSG, European Spondylarthropathy Study Group -- GI, gastrointestinal -- HR, hazards ratio -- IBD, inflammatory bowel disease -- IL, interleukin -- MHC, major histocompatibility complex -- MRI, magnetic resonance imaging -- NSAID, non-steroidal anti-inflammatory drug -- RA, rheumatoid arthritis -- ReA, reactive arthritis -- SIJ, sacroiliac joint -- SpA, spondyloarthropathy -- TNFα, tumour necrosis factor α -- uSpA, undifferentiated spondyloarthropathy 1